LncRNAs as potential therapeutic targets in thyroid cancer

Zeeshan Javed, Faiez Ahmed Shah, Sadegh Rajabi, Qamar Raza, Zaheer Iqbal, Mukhtar Ullah, Touqeer Ahmad, Bahare Salehi, Mehdi Sharifi-Rad, Raffaele Pezzani, Farooq Yaqoob, Haleema Sadia, Marcello Iriti, Javad Sharifi-Rad, William C. Cho

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

29 Citas (Scopus)

Resumen

Thyroid cancer (TC) is the most common cancer of endocrine system. TC can be subdivided into 4 different entities, papillary, follicular, medullary and anaplastic thyroid cancer. Among them, anaplastic thyroid cancer has the poorest prognosis. Exploring new therapeutic approach may entail favorable prediction as well as increasing overall survival rate of patients. Long non-coding RNAs (lncRNAs), have vast implications in different cancer types. Although they are not transcribed into proteins, they can act as a harness in regulating a plethora of biological functions. They have been implicated in a decisive role in gene expression via modulation of both coding and non-coding RNAs. This article discuss the multi-facet role of lncRNA in thyroid cancer biology.

Idioma originalInglés
Páginas (desde-hasta)281-287
Número de páginas7
PublicaciónAsian Pacific Journal of Cancer Prevention
N.º2
DOI
EstadoPublicada - 2020
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'LncRNAs as potential therapeutic targets in thyroid cancer'. En conjunto forman una huella única.

Citar esto